Comparison of Insulin Alone to Insulin With Metformin to Treat Gestational Diabetes Mellitus
Public ClinicalTrials.gov record NCT03651531. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is a prospective, unmasked randomized clinical trial comparing the use of insulin vs combination insulin and metformin for treatment in women diagnosed with gestational diabetes mellitus (GDM). The investigator's hypothesis is that the combination of metformin and insulin will be superior to insulin alone to achieve tight glucose control during pregnancy.
Study identification
- NCT ID
- NCT03651531
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1 participant
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2, 2018
- Primary completion
- Jul 29, 2019
- Completion
- Jul 29, 2019
- Last update posted
- Jul 23, 2020
2018 – 2019
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Women & Infants Hospital | Providence | Rhode Island | 02905 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Gestational Diabetes trials
Other public records listing Gestational Diabetes. Sorted by last update posted; newest first. Not a recommendation.
- NCT07174245: Pregnancy and Postpartum CGM in GDM Recruiting
- NCT06457139: Preventing T2DM After GDM With Immediate Postpartum Screening Recruiting
- NCT05124808: Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes Recruiting
- NCT06571487: Growth Hormone Resistance of Beta-cells A Recruiting
- NCT07565727: Cardiometabolic Disease and Substrate Metabolism Recruiting
- NCT05482789: Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03651531, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 23, 2020 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03651531 live on ClinicalTrials.gov.